Home LiteratureArticle Details
PMID: 3088040 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.

The Journal of clinical investigation ·Vol. 78 ·No. 1 ·1986-07-00 ·Pages 138-44

Colucci M, Paramo JA, Stassen JM, Collen D

Abstract

The influence of endotoxin-induced elevated plasma levels of the fast-acting inhibitor of plasminogen activator (PA-inhibitor) on thrombolysis was investigated in rabbits with a jugular vein thrombus. Infusion of human tissue-type plasminogen activator (t-PA) produced similar degrees of thrombolysis in control and endotoxin-treated rabbits, although no free t-PA could be demonstrated in plasma of endotoxin-treated animals. Infusion of t-PA in an extracorporeal arteriovenous shunt resulted in loss of thrombolytic activity in endotoxin-treated animals but not in control animals. Blood clots superfused in vitro with mixtures of t-PA and normal plasma lysed in contrast to clots superfused with t-PA and PA-inhibitor-rich plasma. However, addition of rabbit lung slices to the plasma surrounding the blood clot, reversed the inhibition of thrombolysis by PA-inhibitor-rich plasma. This indicates that tissue-derived factor(s) are involved in the regulation of in vivo thrombolysis. These hypothetical factor(s) are, however, very unstable in plasma, which has thus far precluded their further characterization.

MeSH Terms
Animals Chromatography, Gel Dose-Response Relationship, Drug Endotoxins/pharmacology Fibrin/metabolism Fibrinolysis/drug effects Glycoproteins/pharmacology Plasminogen Inactivators Rabbits Time Factors Tissue Plasminogen Activator/antagonists & inhibitors
Chemicals
Endotoxins Glycoproteins Plasminogen Inactivators Fibrin Tissue Plasminogen Activator
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Colucci M
Paramo J A
Stassen J M
Collen D
References (23)
23 references, click to expand
  1. Plasminogen: purification from human plasma by affinity chromatography.
    Science. 1970 Dec 4;170(3962):1095-6 PMID: 5475635
  2. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test).
    Clin Chim Acta. 1963 May;8:418-24 PMID: 13996819
  3. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.
    Biochem Biophys Res Commun. 1978 Feb 28;80(4):849-57 PMID: 637870
  4. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.
    Thromb Haemost. 1980 Jun 18;43(2):77-89 PMID: 6450468
  5. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
    J Biol Chem. 1981 Jul 10;256(13):7035-41 PMID: 6787058
  6. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
    Thromb Haemost. 1981 Aug 28;46(2):561-5 PMID: 6795744
  7. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    J Clin Invest. 1983 Feb;71(2):368-76 PMID: 6681615
  8. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay.
    J Lab Clin Med. 1983 Feb;101(2):274-84 PMID: 6681623
  9. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.
    Thromb Haemost. 1982 Dec 27;48(3):266-9 PMID: 6891841
  10. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.
    Biochem Biophys Res Commun. 1983 Jan 27;110(2):392-8 PMID: 6404257
  11. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
    Proc Natl Acad Sci U S A. 1983 May;80(10):2956-60 PMID: 6574465
  12. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6804-8 PMID: 6580616
  13. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.
    Thromb Res. 1984 Mar 1;33(5):523-30 PMID: 6426082
  14. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
    Thromb Res. 1984 Jun 1;34(5):431-7 PMID: 6234678
  15. Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro.
    Thromb Res. 1984 Aug 1;35(3):335-45 PMID: 6431630
  16. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.
    Blood. 1984 Oct;64(4):907-13 PMID: 6434006
  17. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Biochim Biophys Acta. 1984 Nov 6;802(1):111-8 PMID: 6435684
  18. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
    Thromb Haemost. 1984 Jul 29;51(3):392-5 PMID: 6437006
  19. The fast inhibitor of tissue plasminogen activator in plasma during pregnancy.
    Thromb Haemost. 1984 Oct 31;52(2):124-6 PMID: 6441300
  20. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
    J Clin Invest. 1985 Mar;75(3):818-24 PMID: 3920245
  21. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA).
    Thromb Haemost. 1985 Feb 18;53(1):134-6 PMID: 4039472
  22. The fibrin plate method for estimating fibrinolytic activity.
    Arch Biochem Biophys. 1952 Oct;40(2):346-51 PMID: 12997222
  23. Inhibition of plasmin by normal and antiplasmin-depleted human plasma.
    Thromb Res. 1976 Apr;8(4):513-8 PMID: 131986
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1986-07-00
Pages
138-44
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC329542
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com